Milestone Pharmaceuticals Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2017 | — | — | $10.9M |
| Mar 2018 | — | — | $13.2M |
| Jun 2018 | — | — | $17.8M |
| Sep 2018 | — | — | $4.2M |
| Dec 2018 | $4.5M | $88.1M | $85.9M |
| Mar 2019 | $4.3M | $77.6M | $71.2M |
| Jun 2019 | $6.5M | $151.8M | $110.8M |
| Sep 2019 | $9.1M | $141.9M | $106.5M |
| Dec 2019 | $8.5M | $123.4M | $119.8M |
| Mar 2020 | $5.5M | $105.2M | $101.8M |
| Jun 2020 | $5.1M | $93.1M | $53.4M |
| Sep 2020 | $6.6M | $108.8M | $46.9M |
| Dec 2020 | $6.9M | $150.0M | $72.3M |
| Mar 2021 | $6.5M | $138.4M | $71.9M |
| Jun 2021 | $5.9M | $145.5M | $97.8M |
| Sep 2021 | $6.4M | $133.8M | $111.4M |
| Dec 2021 | $7.2M | $119.8M | $114.1M |
| Mar 2022 | $5.0M | $105.8M | $92.2M |
| Jun 2022 | $4.6M | $91.3M | $63.2M |
| Sep 2022 | $8.6M | $85.8M | $37.3M |
| Dec 2022 | $8.1M | $74.5M | $7.6M |
| Mar 2023 | $57.1M | $111.1M | $74.0M |
| Jun 2023 | $56.6M | $97.0M | $32.6M |
| Sep 2023 | $58.6M | $87.1M | $9.9M |
| Dec 2023 | $58.5M | $75.2M | $13.8M |
| Mar 2024 | $56.1M | $96.0M | $10.1M |
| Jun 2024 | $57.3M | $89.2M | $13.3M |
| Sep 2024 | $58.7M | $82.7M | $12.8M |
| Dec 2024 | $62.4M | $75.5M | $25.3M |
| Mar 2025 | $68.0M | $61.9M | $45.1M |
| Jun 2025 | $65.2M | $47.4M | $42.5M |
| Sep 2025 | $67.2M | $87.8M | $46.7M |
| Dec 2025 | $71.8M | $113.6M | $73.0M |
| Mar 2026 | $157.7M | $193.7M | $71.3M |
| Jun 2026 | $163.4M | $181.6M | $169.7M |